Presentation is loading. Please wait.

Presentation is loading. Please wait.

The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.

Published byHansl Hofmann Modified over 6 years ago

Similar presentations

Presentation on theme: "The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard."— Presentation transcript:

1 The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard Grube, MD, Ulrich Gerckens, MD, Raimund Erbel, MD, Holger Eggebrecht, MD, Ralf Zahn, MD, Axel Linke, MD, Horst Sievert, MD, Hans-Reiner Figulla, MD, Karl-Heinz Kuck, MD, Karl Eugen Hauptmann, MD, Ellen Hoffmann, MD, Rainer Hambrecht, MD, Gert Richardt, MD, Stefan Sack, MD, Jochen Senges, MD, Georg Nickenig, MD, Nikos Werner, MD  American Heart Journal  Volume 164, Issue 1, Pages e1 (July 2012) DOI: /j.ahj Copyright © 2012 Mosby, Inc. Terms and Conditions

2 Figure 1 Access site and associated prevalence of PAD in the German TAVI Registry. American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2012 Mosby, Inc. Terms and Conditions

3 Figure 2 Clinical outcomes. Clinical outcomes according to prevalence of PAD. American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2012 Mosby, Inc. Terms and Conditions

4 Figure 3 In-hospital mortality and logistic EuroSCORE. In-hospital mortality (colored bars) and mean logistic EuroSCORE (gray bars) according to access site and prevalence of PAD. American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2012 Mosby, Inc. Terms and Conditions

5 Figure 4 Kaplan-Meier estimates of 30-day mortality. Kaplan-Meier estimates of 30-day mortality according to access site and prevalence of PAD. American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2012 Mosby, Inc. Terms and Conditions

Download ppt "The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard."

Similar presentations

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.
Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.
Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov.

Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov.
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,
Volume 8, Issue 7, Pages (July 2011)

Volume 8, Issue 7, Pages (July 2011)
Volume 13, Issue 9, Pages (September 2016)

Volume 13, Issue 9, Pages (September 2016)
Downstream coronary effects of drug-eluting stents

Downstream coronary effects of drug-eluting stents
Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,
Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes  Hélène Eltchaninoff, MD, Eric Durand,

Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes  Hélène Eltchaninoff, MD, Eric Durand,
Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E
Comparison of Outcomes of Patients With Left Ventricular Ejection Fractions ≤30% Versus ≥30% Having Transcatheter Aortic Valve Implantation (from the.

Comparison of Outcomes of Patients With Left Ventricular Ejection Fractions ≤30% Versus ≥30% Having Transcatheter Aortic Valve Implantation (from the.
Preprocedural high-sensitive troponin predicts survival after transcatheter aortic valve implantation (TAVI)  Derk Frank, Sophia Stark, Matthias Lutz,

Preprocedural high-sensitive troponin predicts survival after transcatheter aortic valve implantation (TAVI)  Derk Frank, Sophia Stark, Matthias Lutz,
Comparative Survival After Transapical, Direct Aortic, and Subclavian Transcatheter Aortic Valve Implantation (Data from the UK TAVI Registry)  Georg.

Comparative Survival After Transapical, Direct Aortic, and Subclavian Transcatheter Aortic Valve Implantation (Data from the UK TAVI Registry)  Georg.
The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction  Mehmet Ergelen, MD, Sevket.

The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction  Mehmet Ergelen, MD, Sevket.
Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.

Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.
Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan.

Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan.
Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:

Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Similar presentations

Ads by Google